/PRNewswire/ The exosome diagnostics and therapeutics market size is set to grow by USD 483.18 million from 2022 to 2027 and register an accelerating CAGR.
A polypeptide known as human epidermal growth factor (EGF) binds to the receptor EGFR, which triggers a series of reactions that activate gene pathways